HomeCompareADKCF vs JNJ

ADKCF vs JNJ: Dividend Comparison 2026

ADKCF yields 3.14% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $5.8K in total portfolio value· pulled ahead in Year 8
10 years
ADKCF
ADKCF
● Live price
3.14%
Share price
$22.50
Annual div
$0.71
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$384.18
Full ADKCF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — ADKCF vs JNJ

📍 JNJ pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADKCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADKCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADKCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADKCF
Annual income on $10K today (after 15% tax)
$266.79/yr
After 10yr DRIP, annual income (after tax)
$326.55/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,659.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADKCF + JNJ for your $10,000?

ADKCF: 50%JNJ: 50%
100% JNJ50/50100% ADKCF
Portfolio after 10yr
$27.4K
Annual income
$2,536.79/yr
Blended yield
9.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ADKCF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADKCF buys
0
JNJ buys
0
No recent congressional trades found for ADKCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADKCFJNJ
Forward yield3.14%2.13%
Annual dividend / share$0.71$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$24.5K$30.3K
Annual income after 10y$384.18$4,689.40
Total dividends collected$3.5K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ADKCF vs JNJ ($10,000, DRIP)

YearADKCF PortfolioADKCF Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,014$313.87$10,592$272.30+$422.00ADKCF
2$12,108$323.07$11,289$357.73+$819.00ADKCF
3$13,287$331.93$12,123$472.89+$1.2KADKCF
4$14,558$340.43$13,141$629.86+$1.4KADKCF
5$15,926$348.59$14,408$846.81+$1.5KADKCF
6$17,397$356.39$16,021$1,151.60+$1.4KADKCF
7$18,978$363.84$18,122$1,588.22+$856.00ADKCF
8← crossover$20,678$370.95$20,930$2,228.20$252.00JNJ
9$22,503$377.73$24,792$3,191.91$2.3KJNJ
10$24,462$384.18$30,274$4,689.40$5.8KJNJ

ADKCF vs JNJ: Complete Analysis 2026

ADKCFStock

Adeka Corporation engages in chemicals, food products, and life science businesses. The company offers polymer additives, such as antioxidants, UV absorbers/hindered amine light stabilizers, nucleating agents/clarifiers, metal deactivators/additives for filled polymers, flame retardants, epoxy type stabilizers/lubricants/processability improvers/water dispersion type stabilizers; plasticizers/PVC stabilizers; and light/thermal curing materials, initiators, polymerizable materials, resist materials, thermal paper materials, semiconductor materials, and circuit materials. Its chemical products also comprise functional polymers, including water borne, epoxy, low chlorine epoxy, and urethane resins; surface specialties, such as general-purpose and functional surfactants, functional cosmetic ingredients, lubricant additives, and base materials for lubricants; propylene glycol, peroxygen chemicals, metal soaps, and inorganic chemicals; and inducing joint fillers and sealing materials, as well as civil engineering and construction materials. The company offers its chemical products to electronics and IT, plastics and rubber, personal care, industrial, liquid crystal display, automotive, and building and construction industries, as well as paints, coatings, and adhesives industries. In addition, it provides food products, such as margarines, shortening products, oils and fats for chocolate, frying oil, whipping cream, concentrated milk type creams, fillings, frozen pie doughs, mayonnaise and dressing, functional foods, and others under the RISU BRAND name. Further, the company engages in various businesses, such as plant facility design; construction and construction management; and facility maintenance, logistics, warehousing, vehicles leasing, real estate, and insurance agency. The company was formerly known as Asahi Denka Co., Ltd. and changed its name to Adeka Corporation in May 2006. The company was incorporated in 1917 and is headquartered in Tokyo, Japan.

Full ADKCF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ADKCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADKCF vs SCHDADKCF vs JEPIADKCF vs OADKCF vs KOADKCF vs MAINADKCF vs ABBVADKCF vs MRKADKCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.